1-20 of 91
Odile Beyne Rauzy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group

Marie Sebert, Thomas Cluzeau, Odile Beyne Rauzy, Aspasia Stamatoulas Bastard, Sophie Dimicoli-Salazar, Sylvain Thepot, Pierre Peterlin, Sophie Park, Marie-Pierre Gourin, Oana Brehar, Cécile Bally, Sébastien Maury, Gaelle Fossard, Lamya Ait Si Selmi, Cendrine Chaffaut, Emmanuelle Clappier, Raphael Itzykson, Fatiha Chermat, Sylvie Chevret, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2021) 138 (Supplement 1): 62.
https://doi.org/10.1182/blood-2021-146932
Published: 2021
Journal Articles

Enasidenib (ENA) Is Effective in Patients with IDH2 Mutated Myelodysplastic Syndrome (MDS) : The Ideal Phase 2 Study By the GFM Group

Lionel Ades, Sophie Dimicoli-Salazar, Marie Sebert, Thomas Cluzeau, Aspasia Stamatoulas Bastard, Kamel Laribi, Gaelle Fossard, Raphael Itzykson, Odile Beyne Rauzy, Alice Garnier, Silke Gloaguen, Norbert Vey, Caroline Le Jeune, Aristoteles Giagounidis, Emmanuel Gyan, Baptiste Perard, Sylvain Thepot, Mario Ojeda, Fatiha Chermat, Kristell Desseaux, Emmanuelle Clappier, Sylvie Chevret, Uwe Platzbecker, Pierre Fenaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 63.
https://doi.org/10.1182/blood-2021-147898
Published: 2021
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT) in Patients with IPSS Low or Intermediate-1 Myelodysplastic Syndrome (MDS): A Prospective Multicenter Phase II Study Based on Donor Availability By the GFM & SFGM-TC "MDS-ALLO-Risk"

Marie Sebert, Cendrine Chaffaut, Sylvain Thepot, Corentin Orvain, Thomas Cluzeau, Michael Loschi, Pierre Peterlin, Patrice Chevallier, Maud d'Aveni, Marie-Thérèse Rubio, Odile Beyne Rauzy, Anne Huynh, Amandine Charbonnier, Nathalie Fegueux, Gaelle Fossard, Stephanie N'guyen-Quoc, Sophie Park, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sylvie Chevret, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2021-146846
Published: 2021
Journal Articles

Association between Megakaryocyte Abnormalities on Bone Marrow Smear and Response to Thrombopoietin Receptor Agonists in Adult Patients with Primary Immune Thrombocytopenia

Ondine Walter, Agnès Ribes, Johanne Germain, Jean-Baptiste Rieu, Thibault Comont, Albertine Plat, Brigitte Rivière, Lauréline Deluche, Lucrecia Delarue, Isabelle Le Goff, Monique Greze, Béatrice Dubourdieu, Odile Beyne-Rauzy, Veronique De Mas, Guillaume Moulis
Journal: Blood
Blood (2021) 138 (Supplement 1): 3160.
https://doi.org/10.1182/blood-2021-151435
Published: 2021
Journal Articles

Long Term Follow-up and Combined Phase 2 Results of Eprenetapopt (APR-246) and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

David A. Sallman, Rami S. Komrokji, Amy E. DeZern, Marie Sebert, Guillermo Garcia-Manero, Ramy Rahmé, David P. Steensma, Jacqueline Lehmann che, Gail J. Roboz, Isabelle Madelaine, Mikkael A. Sekeres, Pierre Peterlin, Kendra Sweet, Odile Beyne Rauzy, Andrew T. Kuykendall, Christian Recher, Amy F McLemore, Aspasia Stamatoullas, Ling Zhang, Lise Willems, Qianxing Mo, Emmanuel Raffoux, Lisa Nardelli, Celine Berthon, Najla Al Ali, Bruno Quesnel, Eric Padron, Greg Korbel, Eyal C. Attar, Hagop Kantarjian, Alan F. List, Lionel Ades, Jeffrey E. Lancet, Pierre Fenaux, Thomas Cluzeau
Journal: Blood
Blood (2021) 138 (Supplement 1): 246.
https://doi.org/10.1182/blood-2021-153286
Published: 2021
Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Thomas Cluzeau, MD PhD, Marie Sebert, MD, Ramy Rahmé, MD, Stefania Cuzzubbo, Anouk Walter-petrich, Jacqueline Lehmann che, Pierre Peterlin, Blandine Beve, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne-Rauzy, Christian Recher, MD PhD, Aspasia Stamatoullas, MD, Lise Willems, MD, Emmanuel Raffoux, MD, Céline Berthon, MD PhD, Bruno Quesnel, Antoine Carpentier, David A Sallman, MD, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 677.
https://doi.org/10.1182/blood-2019-125579
Published: 2019
Journal Articles

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Thibault Comont, Natacha Brun, Johanne Germain, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Phillipe Montané de la Roque, Laurent Prudhomme, Laurent Sailler, MD PhD, Laurent Balardy, Laurent Alric, Christian Recher, MD PhD, Miguel Carreiro, MD, Francis Gaches, Maryse Lapeyre-Mestre, MD PhD, Odile Beyne-Rauzy, Daniel Adoue, Guillaume Moulis, MD PhD, Carmen investigators Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 1083.
https://doi.org/10.1182/blood-2019-122821
Published: 2019
Journal Articles

Immune Thrombocytopenia in Very Elderly Patients: Particularities in Presentation and Management. Results from the Multicenter Prospective Carmen-France Registry

Aurélien Sokal, Thomas de Nadaï, Thibault Comont, Nicolas Limal, Marc Michel, Odile Beyne-Rauzy, Bertrand Godeau, MD, Daniel Adoue, Matthieu Mahévas, Guillaume Moulis, MD PhD, Carmen investigators Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 1091.
https://doi.org/10.1182/blood-2019-126019
Published: 2019
Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Lionel Ades, MD PhD, Agnès Guerci, Kamel Laribi, MD, Pierre Peterlin, Norbert Vey, MD PhD, Sylvain Thepot, MD, Stefan Wickenhauser, Hacene Zerazhi, Aspasia Stamatoullas, MD, Eric Wattel, MD PhD, Christian Recher, MD PhD, Andrea Toma, MD PhD, Krimo Bouabdallah, MD, Thorsten Braun, MD PhD, Odile Beyne-Rauzy, Berengere Gruson, MD, Stephane Cheze, Sophie Park, MD PhD, Thomas Cluzeau, MDPhD, Stanislas Nimubona, MD, Dominique Bordessoule, MD, Riad Benramdane, Bruno Quesnel, Shanti Ame, MD, Stephane De Botton, MD PhD, Fatiha Chermat, Julie Lejeune, Sylvie Chevret, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 467.
https://doi.org/10.1182/blood-2018-99-111756
Published: 2018
Journal Articles

The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Pierre Fenaux, MD PhD, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia-Manero, MD, Rena Buckstein, MD FRCPC, Valeria Santini, María Díez-Campelo, Carlo Finelli, MD, Mario Cazzola, Osman Ilhan, MD, Mikkael A. Sekeres, MD MS, José F. Falantes, Beatriz Arrizabalaga, MD PhD, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, MD PhD, Dominik Selleslag, MD, Amy E. DeZern, MD, Joseph G. Jurcic, MD, Ulrich Germing, MD, Katharina S. Götze, MD, Bruno Quesnel, Odile Beyne-Rauzy, Thomas Cluzeau, MD PhD, Maria Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L Greenberg, MD, Eva Hellström-Lindberg, MD PhD, Amer M. Zeidan, MBBS, MHS, Abderrahmane Laadem, MD, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, MD, Alan F. List, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1.
https://doi.org/10.1182/blood-2018-99-110805
Published: 2018
Journal Articles

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

Louise De Swart, MD, Simon Crouch, MSc, PhD, Marlijn Hoeks, MD, Alex Smith, PhD, Saskia Langemeijer, MD PhD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, Jaroslav Cermak, MD PhD, Reinhard Stauder, MD, Moshe Mittelman, MD, Guillermo Sanz, MD, Eva Hellstrom-Lindberg, MD PhD, Luca Malcovati, MD, Mette Skov Holm, MD PhD, Ulrich Germing, MD, Krzysztof Madry, MD PhD, Antonio Medina de Almeida, MD PhD, Aurelia Tatic, MD, Aleksandar Savic, Njetočka Gredelj-Šimec, MD, Agnes Guerci Bresler, Dominic Culligan, MD, Raphael Itzykson, MD PhD, Odile Beyne-Rauzy, MD, Sophie Park, MD PhD, Corine van Marrewijk, PhD, Nicole M A Blijlevens, David T. Bowen, MD, T. M. de Witte, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1690.
https://doi.org/10.1182/blood.V130.Suppl_1.1690.1690
Published: 2017
Journal Articles

Risk Factors for Bleeding, Including Platelet Count Threshold, in Newly Diagnosed ITP Patients

Marie Piel-Julian, Matthieu Mahévas, Johanne Germain, Laetitia Languille, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Serge Madaule, Laurent Prudhomme, Laurent Sailler, Maryse Lapeyre-Mestre, Nicolas Limal, Odile Beyne-Rauzy, Marc Michel, Daniel Adoue, Bertrand Godeau, Guillaume Moulis, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1041.
https://doi.org/10.1182/blood.V130.Suppl_1.1041.1041
Published: 2017
Journal Articles

Positivity Rates of Tests Used at Immune Thrombocytopenia Diagnosis to Detect Associated Diseases. a Prospective Multicenter Cohort Study of 218 Patients

Guillaume Moulis, MD PhD, Thibault Comont, Johanne Germain, PhD, Anaïs Essilini, Natacha Brun, MD, Claire Dingremont, MD, Brice Castel, MD, Philippe Montané de la Roque, MD, Serge Madaule, MD, Laurent Sailler, MD PhD, Laurent Prudhomme, MD, Sophie Arista, MD, Laurent Balardy, MD, Francis Gaches, MD, Benjamin Hebraud, Cecile Borel, MD, Stéphane Sire, MD, Miguel Carreiro, MD, Guillaume Martin-Blondel, MD PhD, Laurent Alric, MD PhD, Patrick Giraud, MD, Maryse Lapeyre-Mestre, MD PhD, Odile Beyne-Rauzy, MD PhD, Daniel Adoue, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1367.
https://doi.org/10.1182/blood.V128.22.1367.1367
Published: 2016
Journal Articles

Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment

Marie Sebert, MD, Cecile Bally, Pierre Peterlin, MD, Odile Beyne-Rauzy, MD PhD, Laurence Legros, MDPhD, marie Pierre Gourin, MD PhD, Laurence Sanhes, MD, Eric Wattel, MDPhD, Emmanuel Gyan, MD PhD, Sophie Park, MD PhD, Aspasia Stamatoullas, MD, Anne Banos, Kamel Laribi, Simone Jueliger, PhD, Luke Bevan, Cendrine Chaffaut, Rosa Sapena, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2016) 128 (22): 347.
https://doi.org/10.1182/blood.V128.22.347.347
Published: 2016
Journal Articles

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry

Saskia Langemeijer, MD PhD, Louise De Swart, MD, Ge Yu, MSc., Alex Smith, Simon Crouch, PhD, Tom Johnston, PhD, Pierre Fenaux, MD PhD, Argiris Symeonidis, Jaroslav Cermak, Eva Hellstrom-Lindberg, MD PhD, Guillermo Sanz, MD, Reinhard Stauder, MD, Luca Malcovati, MD, Ulrich Germing, Mette Skov Holm, Moshe Mittelman, MD, Krzysztof Madry, MD PhD, Aurelia Tatic, MD, Antonio Almeida, MD PhD, Aleksandar Savic, Sophie Park, MD PhD, Odile Beyne-Rauzy, MD, Raphaël Itzykson, MD PhD, Corine van Marrewijk, PhD, David Bowen, MD PhD, Theo de Witte, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3186.
https://doi.org/10.1182/blood.V128.22.3186.3186
Published: 2016
Journal Articles

Interest in Initiating Corticosteroids By Intravenous Methylprednisolone at Standard Dose in Newly Diagnosed Immune Thrombocytopenia Adults: Results of the Prospective Carmen Registry

Anaïs Essilini, Thibault Comont, Johanne Germain, PhD, Natacha Brun, MD, Claire Dingremont, MD, Brice Castel, MD, Philippe Montané de la Roque, MD, Serge Madaule, MD, Laurent Sailler, MD PhD, Laurent Prudhomme, MD, Sophie Arista, MD, Laurent Balardy, MD, Francis Gaches, MD, Benjamin Hebraud, Cecile Borel, MD, Stéphane Sire, MD, Miguel Carreiro, MD, Guillaume Martin-Blondel, MD PhD, Laurent Alric, MD PhD, Patrick Giraud, MD, Maryse Lapeyre-Mestre, MD PhD, Odile Beyne-Rauzy, MD PhD, Daniel Adoue, MD PhD, Guillaume Moulis, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3736.
https://doi.org/10.1182/blood.V128.22.3736.3736
Published: 2016
Journal Articles

Effect of Pregnancy in Women with a History of Primary Immune Thrombocytopenia Considered As Cured

Thibault Comont, Guillaume Moulis, MD PhD, Karen Delavigne, MD, Pierre Cougoul, MD, Olivier Parant, MD PhD, Beatrice Guyard Boileau, MD, Christian Récher, MDPhD, Daniel Adoue, MD PhD, Odile Beyne Rauzy, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2552.
https://doi.org/10.1182/blood.V128.22.2552.2552
Published: 2016
Journal Articles

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Christian Rose, MD, Olivier Fitoussi, MD, Emmanuel Gyan, MD PhD, Maya Hacini, MD, Shanti Amé, MD, Bernadette Corront, MD, Odile Beyne-Rauzy, MD PhD, Didier Innocent Adiko, MD, Elena-Anca Loppinet, MD, Nadia Ali-Ammar, MD, Eric Wattel, MD PhD, Francois Dreyfus, MD, Stéphane Cheze, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2008.
https://doi.org/10.1182/blood.V128.22.2008.2008
Published: 2016
Journal Articles

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion

Virginie Chesnais, Aline Renneville, Andrea Toma, Jérôme Lambert, Marie Passet, Florent Dumont, Sylvie Chevret, Julie Lejeune, Anna Raimbault, Aspasia Stamatoullas, Christian Rose, Odile Beyne-Rauzy, Jacques Delaunay, Eric Solary, Pierre Fenaux, François Dreyfus, Claude Preudhomme, Olivier Kosmider, Michaela Fontenay
Journal: Blood
Blood (2016) 127 (6): 749–760.
https://doi.org/10.1182/blood-2015-04-640128
Published: 2016
Includes: Supplemental data
Journal Articles

Prognostic Impact of Response According to International Consortium for MDS/MPN Criteria in CMML Treated with Hypomethylating Agents (HMA)

Matthieu Duchmann, Thorsten Braun, MD PhD, Uwe Platzbecker, MD PhD, Lionel Adès, MD PhD, Marie Sébert, MD, François Dreyfus, MD, Sophie Park, MD PhD, Norbert Vey, Odile Beyne Rauzy, MD PhD, Stéphane De Botton, MD PhD, Jean-Baptiste Micol, MD, Céline Berthon, MD PhD, Romain Guieze, MD, Jean-Noel M. Bastie, MD PhD, Éric Solary, MD PhD, Pierre Fenaux, MD PhD, Raphaël Itzykson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2893.
https://doi.org/10.1182/blood.V126.23.2893.2893
Published: 2015